This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 19-21, 2024
Pre-Conference Workshops on March 18, 2024Philadelphia Marriott Downtown | Philadelphia, PA

Caitlin Berry
Senior Principal, Public Policy and Government Affairs at Prime Therapeutics


Caitlin Berry is the Senior Principal, Public Policy and Government Affairs at Prime Therapeutics. With 11 years of experience in the health insurance and pharmacy benefit management sector, she is responsible for managing Prime’s Policy team, developing strategies to manage drug policy issues, and identifying risks and opportunities in the legislative and regulatory arena. Caitlin takes a collaborative approach to relationships with various internal and external stakeholders in order to identify and implement organizational policy priorities, and keeps key partners informed of national trends in the drug policy space.

Agenda Sessions

  • Legislative Disruption—PBM Insights on The Past, Present, and Future of Drug Pricing Policymaking